Led by biomedical data scientist Gregory Way, PhD, MS, the study showcases that by using these two data types simultaneously, scientists can measure fundamentally different aspects of the drug’s biology.  “We believe these two popular methods can be used to our advantage in designing drugs that address the full complexity of biology,” said Way, who is an assistant professor in biomedical informatics at the University of Colorado Anschutz Medical Campus.